Nicole Murphy - 12 Feb 2026 Form 4 Insider Report for BIOGEN INC. (BIIB)

Role
Head of Pharm Ops and Tech
Signature
/s/ Wendell Taylor, attorney in fact for Nicole Murphy
Issuer symbol
BIIB
Transactions as of
12 Feb 2026
Net transactions value
+$585
Form type
4
Filing time
17 Feb 2026, 20:16:40 UTC
Previous filing
10 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Murphy Nicole Head of Pharm Ops and Tech 225 BINNEY STREET, CAMBRIDGE /s/ Wendell Taylor, attorney in fact for Nicole Murphy 17 Feb 2026 0001910644

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIIB Common Stock Purchase $585 +3 +0.02% $195.04 19,611 12 Feb 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIIB Restricted Stock Unit Award $0 +10,560 $0.000000 10,560 13 Feb 2026 Common Stock 10,560 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026.